15^th Asia-Pacific Pharma Congress July 18-20, 2018 Melbourne, Australia

Osama Ibrahim is a highly-experienced Principal research Scientist with particular expertise in the field of microbiology, Cell biology, and bioprocessing for both bio pharmaceuticals and food ingredients. He is knowledgeable in microbial screening, culture improvement; molecular biology, genetic engineering and fermentation research (antibiotics, enzymes, therapeutic proteins, organic acids) and biochemistry for metabolic pathways, enzymes kinetics, enzymes immobilization, bioconversion and analytical biochemistry. Ibrahim was Principal research scientist and External research liaison for Kraft Foods R&D with Universities for research projects related to molecular biology and bioprocessing. He holds three bioprocessing patents and several publications. After retirement from Kraft Foods he formed his own biotechnology company providing technical and marketing consultation for startup biotechnology in United States / Overseas and a key note speaker for international bio conferences. Ibrahim received his B.S. in Biochemistry with honor and two M.S. degrees in Industrial fermentation and in Microbial physiology. He received his Ph.D in Basic Medical Science (Microbiology, Immunology and Molecular biology) from New York Medical College. His research dissertation was on the construction of plasmid for the expression of a fusion protein of VEGF121/ Shiga-like toxin as a therapeutic protein for targeting angiogenesis (cancer treatment). Since 1979 he is a member of American Chemical Society, American Society of Microbiology, and Society of Industrial Microbiology.

Biotechnology, Biopharmaceuticals etc.

Dilip Ghosh has received his PhD in Biomedical Science from University of Calcutta, India. Previously, he held positions in Organon (India) Ltd.; HortResearch, New Zealand; USDA-ARS, HNRCA at Tufts University, Boston; The Smart Foods Centre, & Neptune Bio-Innovation Pty. Ltd., Australia. He is an international speaker, facilitator and author. He is a fellow of American College of Nutrition, professional member of AIFST, and also he is the Editorial Board Member of several journals. He has published more than 70 papers in peer reviewed journals, numerous articles in food and nutrition magazines and 4 books under CRC Press, USA.

Phytopharmaceuticals

Ashraf Abadi has completed his PhD from the College of Pharmacy, University of Florida, USA and Cairo University. He is the head of Pharmaceutical Chemsitry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo and former Dean of the Faculty. He has published more than 80 papers in reputed journals and 7 patents and has been serving as an editorial board member and reviewer of reputed international pharmaceutical sciences journals. He supervised more than 6- Master and Ph.D. theses in the field of Drug Discovery and Pharmaceutical Chemistry.

Pharmaceutical Sciences and Biotechnology

Mohamed EL Houseiny El Sebeay Shams is a Professor of Clinical Pharmacy at Faculty of Pharmacy, University of Mansoura, Egypt. He obtained his doctoral degree (PhD) from Johannes Gutenberg University of Mainz, Germany in 2005. He is an international speaker, facilitator, and author. He is serving also as an advisory/ reviewer as well as an Editorial Board Member of several pharmaceutical journals. His pharmacy experience includes practice in patient care, clinical pharmacogenetics, clinical pharmacokinetics, biopharmaceutics, therapeutic drug monitoring, pharmacoeconomics, medications errors, drug-interactions, and long term care.

Clinical pharmacogenetics, therapeutic drug monitoring, measuring the rate of therapeutic adherence and detection of drug-drug interactions

Md. Faiyazuddin has over 11 years of experience as a teacher & researcher with expertise in Pharmaceutical Nanotechnology & Clinical Nanomedicine. He is currently Principal of the Bihar College of Pharmacy at Magadh University, Patna, India. He is an associate member of Institute of Nanotechnology, Sterling University, Scotland, British Society of Nanomedicine, University of Liverpool, International Society of Aerosol in Medicine and American Lung Association, Chicago.

Nano Dry powders for Asthma Therapy, Nanoconjugates of botanicals in hepatoprotection, Chemopreventive nanodelivery approaches for Anticancer agents, Lipid Nanoparticles for Skin Delivery of Botanicals, Ocular Nanopharmaceutics.